Research/art/teacher profile of a person
Name and surname:
MUDr. Ján Jurenka
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Jurenka
I.2 - Name
Ján
I.3 - Degrees
MUDr.
I.4 - Year of birth
1993
I.5 - Name of the workplace
Department of Infectology and Geographical Medicine, Faculty of Medicine, Comenius University in Bratislava, University Hospital in Bratislava
I.6 - Address of the workplace
Špitálska 24, 813 72 Bratislava
I.7 - Position
university teacher
I.8 - E-mail address
jurenka5@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/31560
I.10 - Name of the study field in which a person works at the university
Internal medicine
I.11 - ORCID iD
0009-0000-6286-2130

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University in Bratislava
II.b - Year
2019
II.c - Study field and programme
General Medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University in Bratislava
II.b - Year
2019
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
University teacher Faculty of Medicine, Comenius University in Bratislava 2019

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
infectology general medicine II general medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
5
VI.1.b - Over the last six years
5
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
3
VI.1.b - Over the last six years
3
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Dababseh MMO, Sabaka P, Duraníková O, et al. Delayed Antibody Response in the Acute Phase of Infection Is Associated with a Lower Mental Component of Quality of Life in Survivors of Severe and Critical COVID-19. J Clin Med. 2024;13(7):1938. Published 2024 Mar 27. doi:10.3390/jcm13071938 (2022: IF: 3.9, Q2 JCR, Q1 SJR)

2

Jurenka J, Nagyová A, Dababseh M, et al. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep. 2022;14(6):1004-1016. Published 2022 Dec 11. doi:10.3390/idr14060100 (2022: IF 3.2, Q3 JCR, Q2 SJR)

3

Mihalov P, Hodosy J, Koščálová A, Čaprnda M, Kachlíková M, Jurenka J, Bendžala M, Sabaka P. Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit. Can J Infect Dis Med Microbiol. 2023 Sep 14;2023:4951273. doi: 10.1155/2023/4951273. PMID: 37745269; PMCID: PMC10513818. (2021: IF 2.585, Q3 JCR, Q3 SJR).

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Jurenka J, Nagyová A, Dababseh M, et al. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep. 2022;14(6):1004-1016. Published 2022 Dec 11. doi:10.3390/idr14060100 (2022: IF 3.2, Q3 JCR, Q2 SJR)

2

Dababseh MMO, Sabaka P, Duraníková O, et al. Delayed Antibody Response in the Acute Phase of Infection Is Associated with a Lower Mental Component of Quality of Life in Survivors of Severe and Critical COVID-19. J Clin Med. 2024;13(7):1938. Published 2024 Mar 27. doi:10.3390/jcm13071938 (2022: IF: 3.9, Q2 JCR, Q1 SJR)

3

Mihalov P, Hodosy J, Koščálová A, Čaprnda M, Kachlíková M, Jurenka J, Bendžala M, Sabaka P. Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit. Can J Infect Dis Med Microbiol. 2023 Sep 14;2023:4951273. doi: 10.1155/2023/4951273. PMID: 37745269; PMCID: PMC10513818. (2021: IF 2.585, Q3 JCR, Q3 SJR).

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts